STI surge in Europe signals broader drug-resistant infection spread, expert warns
A surge in sexually transmitted infections in Europe should be seen as an early warning sign for the global spread of drug-resistant bacteria, according to an article in The Guardian. The piece argues that antimicrobial resistance (AMR) is no longer confined to hospitals but is circulating within communities and across borders, facilitated by modern travel and urban density. It highlights an unprecedented spike in drug-resistant gonorrhoea cases, with 82 million new gonorrhoea infections globally in 2020, the majority in low- and middle-income countries (LMICs). Extensively drug-resistant gonorrhoea strains detected in Cambodia have spread to France and Australia. The article notes that one in six bacterial infections is now resistant to first-line antibiotics, and there are nearly 5 million AMR-related deaths each year, a figure expected to rise by 70% by 2050. It calls for a new model for antibiotic development, citing the not-for-profit development of zoliflodacin for multidrug-resistant gonorrhoea as an example.
What’s reported
Key figures
Sources: The Guardian
